Study #2023-1021
STRICT - Surveillance with Troponin during immune checkpoint therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Diagnostic Test: Troponin surveillance
Description
To learn if monitoring blood levels of heart injury (troponin levels) in cancer participants treated with immune checkpoint inhibitors will lead to decreased heart-related side effects.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Immune Checkpoint Therapy
Study phase:
Phase III
Physician name:
Nicolas Palaskas
Department:
Cardiology
For general questions about clinical trials:
1-888-597-3084
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.